139 related articles for article (PubMed ID: 36272958)
1. Radiotherapy utilisation rates for patients with cancer as a function of age: A systematic review.
Mackenzie P; Vajdic C; Delaney G; Comans T; Morris L; Agar M; Gabriel G; Barton M
J Geriatr Oncol; 2023 Apr; 14(3):101387. PubMed ID: 36272958
[TBL] [Abstract][Full Text] [Related]
2. Development of an age- and comorbidity- adjusted optimal radiotherapy utilisation rate for lung, rectal, prostate and cervical cancers.
Mackenzie P; Vajdic C; Delaney G; Comans T; Agar M; Gabriel G; Barton M
Radiother Oncol; 2023 Nov; 188():109862. PubMed ID: 37619661
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting radiotherapy utilisation in geriatric oncology patients in NSW, Australia.
Mackenzie P; Vajdic C; Delaney G; Gabriel G; Agar M; Comans T; Barton M
Tech Innov Patient Support Radiat Oncol; 2020 Dec; 16():17-23. PubMed ID: 33385070
[TBL] [Abstract][Full Text] [Related]
4. Development of an age- and comorbidity adjusted- optimal radiotherapy utilisation rate for women with breast cancer.
Mackenzie P; Vajdic C; Delaney G; Comans T; Agar M; Gabriel G; Barton M
J Geriatr Oncol; 2022 Jul; 13(6):844-849. PubMed ID: 35514015
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy in rectal cancer: development, adequacy and radiotherapy utilisation rate. A comparative analysis with the most frequent tumour sites.
García Cabezas S; Palacios Eito A; Martínez Paredes M; Rivin del Campo E
Clin Transl Oncol; 2011 Feb; 13(2):115-20. PubMed ID: 21324800
[TBL] [Abstract][Full Text] [Related]
6. Provincial variations in radiotherapy utilization as a measure of access: A pan-Canadian study.
Chan J; Brown E; Dennis K; Milosevic M; Brundage M
Radiother Oncol; 2022 Feb; 167():122-126. PubMed ID: 34942281
[TBL] [Abstract][Full Text] [Related]
7. Estimation of an optimal utilisation rate for palliative radiotherapy in newly diagnosed cancer patients.
Jacob S; Wong K; Delaney GP; Adams P; Barton MB
Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):56-64. PubMed ID: 19969443
[TBL] [Abstract][Full Text] [Related]
8. Impact of radiotherapy underutilisation measured by survival shortfall, years of potential life lost and disability-adjusted life years lost in New South Wales, Australia.
Batumalai V; Shafiq J; Gabriel G; Hanna TP; Delaney GP; Barton M
Radiother Oncol; 2018 Nov; 129(2):191-195. PubMed ID: 29983259
[TBL] [Abstract][Full Text] [Related]
9. Actual Versus Optimal Radiotherapy Utilisation for Metastatic Cancer Patients in the 45 and Up Study Cohort, New South Wales.
Yap ML; O'Connell DL; Goldsbury DE; Weber MF; Barton MB
Clin Oncol (R Coll Radiol); 2021 Oct; 33(10):650-660. PubMed ID: 33750600
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy access in Belgium: How far are we from evidence-based utilisation?
Lievens Y; De Schutter H; Stellamans K; Rosskamp M; Van Eycken L;
Eur J Cancer; 2017 Oct; 84():102-113. PubMed ID: 28802187
[TBL] [Abstract][Full Text] [Related]
11. Hyperbaric oxygenation for tumour sensitisation to radiotherapy.
Bennett MH; Feldmeier J; Smee R; Milross C
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD005007. PubMed ID: 29637538
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Use of primary radiotherapy for rectal cancer in the Netherlands between 1997 and 2008: a population-based study.
Jobsen JJ; Aarts MJ; Siesling S; Klaase J; Louwman WJ; Poortmans PM; Lybeert ML; Koning CC; Struikmans H; Coebergh JW
Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e1-8. PubMed ID: 21968247
[TBL] [Abstract][Full Text] [Related]
14. Changes to radiotherapy utilisation in Western NSW after the opening of a local service.
Butler SM
J Med Radiat Sci; 2017 Dec; 64(4):251-258. PubMed ID: 28160454
[TBL] [Abstract][Full Text] [Related]
15. Utilisation of radiotherapy in lung cancer: A scoping narrative literature review with a focus on the introduction of evidence-based therapeutic approaches in Europe.
Corral J; Borras JM; Lievens Y
Clin Transl Radiat Oncol; 2024 Mar; 45():100717. PubMed ID: 38226026
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy utilization in developing countries: An IAEA study.
Rosenblatt E; Fidarova E; Zubizarreta EH; Barton MB; Jones GW; Mackillop WJ; Cordero L; Yarney J; Lim G; Gan JV; Cernea V; Stojanovic-Rundic S; Strojan P; Kochbati L; Quarneti A
Radiother Oncol; 2018 Sep; 128(3):400-405. PubMed ID: 29859755
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.
Hummel S; Simpson EL; Hemingway P; Stevenson MD; Rees A
Health Technol Assess; 2010 Oct; 14(47):1-108, iii-iv. PubMed ID: 21029717
[TBL] [Abstract][Full Text] [Related]
18. No. 385-Indications for Pelvic Examination.
Evans D; Goldstein S; Loewy A; Altman AD
J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
[TBL] [Abstract][Full Text] [Related]
19. Determining the need and utilization of radiotherapy in cancers of the breast, cervix, lung, prostate and rectum: A population level study.
Shack L; Lu S; Weeks LA; Craighead P; Kerba M
Radiother Oncol; 2017 Jan; 122(1):152-158. PubMed ID: 28012795
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
